Anti-SARS-CoV2 antibody-mediated cytokine release syndrome in a patient with acute promyelocytic leukemia
급성 전골수구성 백혈병 환자의 항 SARS-CoV2 항체 매개 사이토카인 방출 증후군
Case Reports
[키워드] Activation
Acute promyelocytic leukemia
acute respiratory distress
ADE
Administered
administration
Admission
advanced age
adverse event
Anemia
antibody
antibody treatment
Antibody-dependent enhancement
APL
approach
Bone marrow
bruise
Case report
Clinical deterioration
complex
Coronavirus disease 2019
COVID-19 symptoms
CRS
Cytokine release syndrome
death
Diagnosis
disease
evidenced
exacerbated
Factor
female
hematological
high risk
highlight
IL-10
IL-6
IL-8
immune
immune activation
immunization
Infection
Inpatients
Laboratory
leukemia
leukemic
life-threatening
limit
nasal
passive immunization
Patient
positive
potential risk
radiological
rapid increase
reported
SARS-CoV-2
SARS-CoV-2 RT-PCR
SARS-CoV-2 testing
SARS-CoV2
serum cytokine
severe COVID-19
syndrome
tested
theoretical risk
therapeutic
therapy-related immunosuppression
throat swab
TNFα
viral burden
viral infection
[DOI] 10.1186/s12879-022-07513-0 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1186/s12879-022-07513-0 PMC 바로가기 [Article Type] Case Reports